Get started
Author

Annamaria De Giorgi

FGFR as potential target in the treatment of squamous non small cell lung cancer
2015 · Marcello Tiseo, Francesco Gelsomino, et al. · Cancer Treatment Reviews · 65
Transforming growth factor-β enhances adhesion of melanoma cells to the endotheliumin vitro
1997 · Anna Teti, Annamaria De Giorgi, et al. · International Journal of Cancer · 32
PDF
Clinical outcome and molecular characterization of brain metastases from esophageal and gastric cancer: a systematic review
2017 · Michele Ghidini, Fausto Petrelli, et al. · Medical Oncology · 30
Abscopal effect as part of treatment of oligometastatic head and neck cancer: A case report
2021 · Giulia Mazzaschi, Chiara Tommasi, et al. · Clinical Case Reports · 11
PDF
Impact of laterality and mucinous histology on relapse-free and overall survival in a registry-based colon cancer series
2019 · Francesca Negri, Annamaria De Giorgi, et al. · Scientific Reports · 9
PDF
Fingerprint Change: Not Visible, But Tangible
2017 · Francesca V. Negri, Annamaria De Giorgi, et al. · Journal of Forensic Sciences · 7
Viral hepatitis and immunotherapy outcome in advanced hepatocellular carcinoma: A comprehensive umbrella review of 15 meta-analyses
2026 · Fausto Petrelli, Silvia Colombo, et al. · Critical Reviews in Oncology/Hematology · 4
Cyclin-dependent kinase inhibitors plus aromatase inhibitor in first-line treatment hormone-receptor–positive/HER2-negative advanced breast cancer women with or without visceral disease: time to turn page?
2020 · Olga Nigro, Cristina Marrazzo, et al. · Anti-Cancer Drugs · 4
Metastatic basal cell carcinoma to the bone: A case of bone metastasis in uncommon sites
2022 · Olga Nigro, Claudio Chini, et al. · Dermatology Reports · 3
PDF
Fibromatosis-Like Metaplastic Breast Carcinoma Mimicking IgG4-Related Sclerosing Mastitis: a Case Report
2021 · Francesca Rita Ogliari, Annamaria De Giorgi, et al. · SN Comprehensive Clinical Medicine · 3
Long-term follow up (FU) of patients with durable complete response (DCR) after chemotherapy (CT) and HER2-targeting systemic therapy (HER2-Tx) for HER2+ metastatic breast cancer (MBC).
2014 · Giuseppe Gullo, Annamaria De Giorgi, et al. · Journal of Clinical Oncology · 2
Treatment-Induced PD-L1 Dynamics and Temporal Heterogeneity in Locally Advanced and Metastatic Gastroesophageal Cancer—A Systematic Review
2026 · Marharyta Khaustova, Elisabetta Liberanome, et al. · Cancers
Upfront Chemotherapy Versus Immediate Surgery for Operable Pancreatic Cancer: An Umbrella Review of Meta-Analyses
2026 · Michele Ghidini, Giuseppe Ietto, et al. · Cancers
PDF
Cdk Inhibitors Plus Letrozole in First-line Treatment Hr-positive/her2-negative Advanced Breast Cancer (abc) Women With Visceral Disease: Time to Turn Page?
2019 · Elisa Gallerani, Olga Nigro, et al. · The Breast
Histological subtype analysis of colon cancer: A population-based study—Different sides and different diseases.
2015 · Francesca Negri, Annamaria De Giorgi, et al. · Journal of Clinical Oncology
Effect of adjuvant trastuzumab (Tadj) therapy (Tx) for early-stage breast cancer (ESBC) on demographics, survival and likelihood of durable complete response (DCR) of HER2+ metastatic breast cancer (HMBC): A 15-year study.
2015 · Alessandra Zacchia, Giuseppe Gullo, et al. · Journal of Clinical Oncology
Transforming growth factor‐β enhances adhesion of melanoma cells to the endothelium in vitro
1997 · Anna Teti, Annamaria De Giorgi, et al. · International Journal of Cancer
Works count: 17
Citation count: 170
H-index: 6
I10-index: 4
Year
Topic
Type